FDA Panel To Vote On Hologic’s Permanent Birth Control Device Next Month
This article was originally published in The Gray Sheet
Executive Summary
Hologic's PMA for the Adiana permanent female birth control product will be considered by an FDA advisory panel Dec. 13, the agency said Nov. 8